Align Technology, Inc. (LON:0HCK)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,471	12,434	16,475	13,673	38,271	30,862
Market Cap Growth	-30.35%	-24.53%	20.50%	-64.27%	24.01%	85.86%
Enterprise Value	6,859	11,703	15,553	12,826	37,428	30,474
Last Close Price	102.64	165.29	216.62	171.77	491.66	390.13
PE Ratio	23.39	36.94	47.15	45.56	67.12	23.73
PS Ratio	2.58	3.89	5.43	4.41	13.11	17.05
PB Ratio	2.62	4.04	5.78	4.57	14.30	13.03
P/TBV Ratio	3.08	4.71	6.71	5.32	16.75	15.85
P/FCF Ratio	-	25.00	34.51	59.51	67.17	83.07
P/OCF Ratio	-	21.09	26.71	28.97	44.20	63.63
EV/Sales Ratio	2.29	3.66	5.13	4.14	12.82	16.83
EV/EBITDA Ratio	10.86	17.86	24.77	19.82	46.70	86.55
EV/EBIT Ratio	14.11	21.69	30.14	23.63	51.90	107.46
EV/FCF Ratio	15.27	23.53	32.58	55.82	65.69	82.02
Debt / Equity Ratio	0.02	0.03	0.04	0.04	0.04	0.03
Debt / EBITDA Ratio	0.11	0.14	0.15	0.15	0.11	0.17
Debt / FCF Ratio	0.15	0.19	0.21	0.46	0.16	0.17
Asset Turnover	0.64	0.65	0.64	0.63	0.73	0.67
Inventory Turnover	4.74	4.34	3.63	3.87	5.51	5.64
Quick Ratio	1.01	1.02	0.98	1.04	1.12	1.22
Current Ratio	1.23	1.22	1.18	1.26	1.30	1.40
Return on Equity (ROE)	11.41%	11.26%	12.31%	10.01%	22.52%	77.55%
Return on Assets (ROA)	6.50%	6.87%	6.83%	6.88%	11.33%	6.60%
Return on Capital (ROIC)	10.20%	10.93%	10.98%	10.94%	17.27%	10.24%
Return on Capital Employed (ROCE)	15.20%	16.20%	16.40%	16.30%	24.30%	11.00%
Earnings Yield	4.28%	2.71%	2.12%	2.20%	1.49%	4.21%
FCF Yield	6.01%	4.00%	2.90%	1.68%	1.49%	1.20%
Buyback Yield / Dilution	2.47%	2.06%	2.36%	1.57%	-0.56%	1.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.